Tsung-Ling Lee (李崇菱)

Members

Assistant Professor, Graduate Institute of Health and Biotechonology Law, Taipei Medical University

Brief Biography

Tsung-Ling Lee is an Assistant Professor of Law with the Taipei Medical University, and a Ministry of Science ofTechnology Young Scholar Fellow (2019-2024). Her main research areas are in Health Law and Ethics,
International Law and International Relations, Public International Law and Global Governance. Tsung-Ling obtained her Bachelor of Medical Science from the University of Sydney, and studied Law at the National Taiwan University. She then pursued a Master of laws and a Doctor of Juridical Science with a scholarship from the government and Georgetown University Law Center (Georgetown University). Tsung-Ling received her doctorate degree in 2015, her dissertation examines the proper role of government in governing non-communicable diseases, focusing on the interactions between domestic and international institutions as a function of norms dissemination. Her dissertation on Behavioral Economics and risk regulations won the Risk Policy and Law Specialty Award in 2013.

In 2015, Tsung-Ling was appointed as a Postdoctoral Fellow with Asia Research Institute, National University of Singapore. She continued her work on transnational regulatory theory and applied it to the 2014 Ebola crisis,where Tsung-Ling was invited to present her findings at the prestigious Annual American Society of International Law Research Forum. From 2015-2018, Tsung-Ling worked as a Research Fellow with the Center for Biomedical Ethics (CBmE), National University of Singapore. While at the CBmE, she led an interdisciplinary collaborative study between the University of Sydney and the National University of Singapore, the research focused on the proper role of the World Health Organization in innovative treatments, and is published in the Bulletin of the
World Health Organization.

Tsung-Ling’s current research includes a comparative study on the political economy of the regenerative medicine market in EU, Japan and Taiwan, examining how global market force shapes domestic biomedical innovation. Tsung-Ling other research projects include an examination of ASEAN health governance and development, focusing on the normative role of the international organization in the regional; investigation on how to govern new health security risks stemming from genome editing technology globally through the rule of law. Tsung-Ling writes on emerging domestic and international health issues, with a focus on the interplay between domestic and international norms that inform regulatory and policy decisions at national and global levels.

PUBLICATIONS

Book review, TAIWAN JOURNAL OF INTERNATIONAL LAW, (reviewing Foundations of Global Health & Human Rights, eds Lawrence Gostin and Benjamin Mason Meier (2020))(forthcoming, 2021)

Tsung-Ling Lee, Legal preparedness as part of COVID-19 response: the first 100 days in Taiwan, BMJ Global Health, (May, 2020)

Tsung-Ling Lee, Global Health in a Turbulent Time: A Commentary (March 27, 2020). Asian Journal of WTO & International Health Law and Policy, 15:1, pp. 27-60.

Tsung-Ling Lee, Two Minutes to Midnight – What International Law can do about Genome Editing,

Asian Journal of WTO & International Health Law and Policy 14:1, 227-265(2019).

Tsung-Ling Lee, Making International Health Regulations Work: Lessons from the 2014 Ebola Outbreak, 49 Vanderbilt Journal of Transnational Law 931 (2016) (available at https://www.vanderbilt.edu/jotl/2016/12/making-international-health-regulations-work-lessons-fromthe-2014-ebola-outbreak/).

Tsung-Ling Lee, Tamra Lysaght, Adaptive Pathways Regulations for Stem Cells: Accelerating Access to Medicine or Deregulating Access to Market, SCRiPTed – a Journal of Law, Technology & Society,81-99 (June 2017).

Book Review, EUROPEAN JOURNAL OF RISK REGULATION (Sept. 2016), (Reviewing Bernard Harcourt, Exposed: Desire and Disobedience in the Digital Age, (2016))
Tsung-Ling Lee, Dissecting Non-Communicable Diseases Policies: Why International Human Rights Are Relevant in the Current Regulatory State, 106 American Society of International Law Proceedings 260, 260 (2012).

Calvin Wai-Loon Ho, Tsung-Ling Lee, Global Governance of Anti-microbial resistance: A Legal and Regulatory Toolkit, in ETHICS AND ANTIMICROBIAL RESISTANCE: COLLECTIVE RESPONSIBILITY FOR GLOBAL PUBLIC HEALTH (Euzebiusz Jamrozik, Michael Selgelid eds.)(Springer)(2020).

Chang-fa Lo, Tsai-yu Lin, Fong-ching Chang, Chuan-feng Wu, Pei-kan Yang, Chien-huei Wu, Chi Chung, Chi-wei Chan, Yung-ya Huang, Tsung-Ling Lee, Pei-ju Wang, Shih-yu Yang, Yi-hsin Yeh, 2010, Reducing Tobacco Growing in Taiwan and Government Intervention: Challenges andOpportunities, Asian Journal of WTO & International Health Law and Policy, 5(1), 208-247.

SCIENTIFIC PUBLICATIONS

Tsung-Ling Lee, Time for a Committee C for the WHO? COVID-19 and a more inclusive participation and accountable WHO. Journal of Global Health Reports. 2020;4:e2020035. doi:10.29392/001c.12842 (2020)

Tsung-Ling Lee, Tamra Lysaght, Conditional Approvals for Autologous Stem Cells: Conflicting Norms,Social Inequalities and Institutional Legitimacy, Perspectives in Biology and Medicine, (Winter, 2018).

Tsung-Ling Lee, Tamra Lysaght, Wendy Lipworth, Ian Kerridge, Tereza Hendl, Megan Munsie, Cameron Stewart, Regulating the Stem Cell Industry: Needs and Responsibilities. Bulletin of the World
Health Organization, 2017, Volume 95 (Number 9). 10.2471/blt.16.189977.

Markus Labude, Tsung-Ling Lee, Competencies of Member States Concerned and of Ethics Committees to assess trial applications under the new EU Clinical Trials Regulation, European Journal of Risk Regulation, (June 2017).

Tamra Lysaght, Wendy Lipworth, Tereza Hendl, Ian Kerridge, Tsung-Ling Lee, Megan Munsie,Catherine Waldby, Cameron Stewart (2017), The Deadly Business of an Unregulated Global Stem Cell Industry, Journal of Medical Ethics, doi: 10.1136/medethics-2016-104046 (IF: 1.764).

Tamra Lysaght, Tsung-Ling Lee, Sangeetha Watson, Zohar Lederman, Michele Bailey, Paul Anantharajah Tambyah, Zika in Singapore: Insights from One Health and Social Medicine, Singapore
Medical Journal, 2016 Oct; 57(10): 528–529

BAR ADMISSION & PROFESSIONAL AFFILIATIONS

New York State (2014)
American Society of International Law, member (2015)
Human Genome Organisation, member (2019)
International Society for Cell and Gene Therapy, member (2019)

PEER REVIEWER

Asia Pacific Journal of Health Law & Ethics
Asian Journal of WTO & International Health Law and Policy
Bioethics
BMJ Global Health
Bulletin of the World Health Organization
European Journal of Risk Regulation
Lancet Regional Health – Western Pacific